Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin-Jie Yan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Acta Pharmacologica Sinica|June 7, 2026
Repurposing atorvastatin for uterine leiomyosarcoma: mevalonate pathway inhibition yields preclinical antitumor efficacyFang-Liang Zhou, Yi-Bin Wu, Wen Wang, et al.
Current Medicinal Chemistry|July 5, 2022
Ferroptosis and Hydrogen Sulfide in Cardiovascular DiseaseZe-Fan Wu, Bin-Jie Yan, Wen Luo, et al.
Current Pharmaceutical Design|August 17, 2022
Hippo: A New Hub for Atherosclerotic DiseaseXi-Yan Liu, Kun Zhou, Kai-Jiang Tian, et al.
European Journal of Pharmacology|February 2, 2021
Effects of gut microbiota on atherosclerosis through hydrogen sulfideDan-Dan Gui, Wen Luo, Bin-Jie Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2021
Sestrin2 in atherosclerosisZhen Tian, Bin-Jie Yan, Wen Luo, et al.
Cell Cycle (Georgetown, Tex.)|July 16, 2021
A promising field: regulating imbalance of EndMT in cardiovascular diseasesKun Zhou, Kai-Jiang Tian, Bin-Jie Yan, et al.
Molecular and Cellular Biochemistry|October 23, 2021
Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathyNian-Hua Deng, Wen Luo, Dan-Dan Gui, et al.
Cardiovascular Drugs and Therapy|February 25, 2020
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular DiseasesWen Luo, Dan-Dan Gui, Bin-Jie Yan, et al.
Current Medicinal Chemistry|March 7, 2020
The Role of Ubiquitin E3 Ligase in AtherosclerosisZhi-Xiang Zhou, Zhong Ren, Bin-Jie Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2019
Tissue factor pathway inhibitor in atherosclerosisHou-Qin Yuan, Ya-Meng Hao, Zhong Ren, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Acta Pharmacologica Sinica|June 7, 2026
Repurposing atorvastatin for uterine leiomyosarcoma: mevalonate pathway inhibition yields preclinical antitumor efficacyFang-Liang Zhou, Yi-Bin Wu, Wen Wang, et al.
Current Medicinal Chemistry|July 5, 2022
Ferroptosis and Hydrogen Sulfide in Cardiovascular DiseaseZe-Fan Wu, Bin-Jie Yan, Wen Luo, et al.
Current Pharmaceutical Design|August 17, 2022
Hippo: A New Hub for Atherosclerotic DiseaseXi-Yan Liu, Kun Zhou, Kai-Jiang Tian, et al.
European Journal of Pharmacology|February 2, 2021
Effects of gut microbiota on atherosclerosis through hydrogen sulfideDan-Dan Gui, Wen Luo, Bin-Jie Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2021
Sestrin2 in atherosclerosisZhen Tian, Bin-Jie Yan, Wen Luo, et al.
Cell Cycle (Georgetown, Tex.)|July 16, 2021
A promising field: regulating imbalance of EndMT in cardiovascular diseasesKun Zhou, Kai-Jiang Tian, Bin-Jie Yan, et al.
Molecular and Cellular Biochemistry|October 23, 2021
Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathyNian-Hua Deng, Wen Luo, Dan-Dan Gui, et al.
Cardiovascular Drugs and Therapy|February 25, 2020
Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular DiseasesWen Luo, Dan-Dan Gui, Bin-Jie Yan, et al.
Current Medicinal Chemistry|March 7, 2020
The Role of Ubiquitin E3 Ligase in AtherosclerosisZhi-Xiang Zhou, Zhong Ren, Bin-Jie Yan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2019
Tissue factor pathway inhibitor in atherosclerosisHou-Qin Yuan, Ya-Meng Hao, Zhong Ren, et al.
Pageof 1